PCM
BHVN

PenderFund Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

PenderFund Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,530
Closed -$319K – 212
2022
Q3 		$319K Buy
+1,530
New +$319K 0.1% 96